Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Denmark also uses Ozempic’s sister drug approved for weight loss, Wegovy, and has similarly grappled with ... that Kennedy ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

Robert F. Kennedy Jr., and his wife Cheryl Hines arrive before President-elect Donald Trump speaks during an America First ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.